Product Description: c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer. IC50 value:Target: c-MetMore details please refer to Patent WO 2012015677 A1.
Applications: Cancer-Kinase/protease
Formula: C17H14N8S
References: [1]PCT Int. Appl. (2012), WO 2012015677 A1 20120202.